Evaluation and treatment of low responders

Seminars in Reproductive Endocrinology

Volumn 14, Issue 4, 1996, Pages 317-337

  Scott Jr , Richard T ^a  

^a SAINT BARNABAS MEDICAL CENTER   (United States)

Author keywords

fertility; follicle stimulating hormone; in vitro fertilization; ovarian function; ovarian reserve; ovary; ovulation induction

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; ESTRADIOL; ESTROGEN; FOLLITROPIN; GONADOTROPIN; GROWTH HORMONE;

AGING; DATA ANALYSIS; DIFFERENTIAL DIAGNOSIS; ESTRADIOL BLOOD LEVEL; ESTROGEN BLOOD LEVEL; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; GONADOTROPIN RELEASE; HUMAN; MASS SCREENING; OVARY FUNCTION; OVARY INSUFFICIENCY; OVULATION INDUCTION; PREDICTION; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REVIEW;

EID: 8044253438     PISSN: 07348630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1067977     Document Type: Review

References (63)

1. Jacobs SL, Metzger DA, Dodson WC, Haney AF: Effect of age on response to human menopausal gonadotropin stimulation. J Clin Endocrinol Metab 71:1525-1530, 1990
2. Scott RT, Toner JF, Muasher SJ, Oehninger SC, Robinson S, Rosenwaks Z: Follicle stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril 51:651-654, 1989
3. Toner JP, Philput CB, Jones GS, Muasher SJ: Basal follicle stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril 55:784-791, 1991
4. Pearlstone AC, Fournet N, Gambone JC, Pang SC, Buyalos RP: Ovulation induction in women age 40 and older: The importance of basal follicle-stimulating hormone level and chronological age. Fertil Steril 58:674-679, 1992
5. Cameron IT, O'Shea FC, Rolland JM, Hughes EG, de Kretser DM, Healy DL: Occult ovarian failure: A syndrome of infertility, regular menses, and elevated follicle-stimulating hormone concentrations. J Clin Endocrinol Metab 67:1190-1194, 1988
6. Sherman BM, West JH, Korenman SG: The menopausal transition: Analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women. J Clin Endocrinol Metab 42:629-636, 1976
7. Sherman BM, Korenman SG: Hormonal characteristics of the human menstrual cycle throughout reproductive life. J Clin Invest 55:699-706, 1975
8. Adamopoulos DA, Loraine JA, Dove GA: Endocrinological studies in women approaching the menopause. J Obstet Gynecol Brit Common 78:62-79, 1971
9. Reyes FI, Winter JSD, Faiman C: Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follicle-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels. Am J Obstet Gynecol 129:557-564, 1977
10. Lenton E A, Sexton L, Lee S, Cooke ID: Progressive changes in LH and FSH and LH:FSH ratio in women throughout reproductive life. Maruritas 10:35-43, 1988
11. Metcalf MG, Livesey JH: Gonadotrophin excretion in fertile women: Effect of age and the onset of the menopausal transition. J Endocr 105:357-362, 1985
12. Muasher SJ, Oehninger S, Simonetti S, Matta J, Ellis LM, Liu HC, Jones GS, Rosenwaks Z: The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome. Fertil Steril 50:298-307, 1988
13. Hughes EG, Robertson DM, Handlesman DJ, Hayward S, Healy DL, de Kretser DM: Inhibin and estradiol responses to ovarian hyperstimulation: Effects of age and predictive value for in vitro fertilization outcome. J Clin Endocrinol Metab 70:358-364, 1990
14. McClachlan RI, Healy DL, Robertson DM, de Kretser DM, Burger HG: Plasma inhibin levels during gonadotropin induced ovarian hyperstimulation for IVF: A new index of follicular function? Lancet 1:1233-1234, 1986
15. Scott RT, Hofmann GE, Oehninger S, Muasher SJ: Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization. Fertil Steril 297-302, 1990
16. Khalifa E, Toner JP, Muasher SJ, Acosta A A: Significance of basal follicle-stimulating hormone levels in women with one ovary in a program of in vitro fertilization. Fertil Steril 57:835-839, 1992
17. Licciardi FL, Liu HC, Rosenwaks Z: Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil Steril 64:991-994, 1995
18. Smotrich DB, Widra EA, Gindoff PR, Levy MU, Hall JL, Stillman RJ: Prognostic value of day 3 estradiol on in vitro fertilization outcome. Fertil Steril 64:1136-1140, 1995
19. Kreiner D, Itskovitz J, Droesch K, Navot D, Liu H-C, Rosenwaks Z: Serum follicle stimulating hormone inhibition is a marker for preovulatory oocytes in in-vitro fertilization. Hum Reprod 4:381-383, 1989
20. Navot D, Rosenwaks Z, Margalioth EJ: Prognostic assessment of female fecundity. Lancet 2:645-647, 1987
21. Loumaye E, Billion JM, Mine JM, Psalit I, Pensis M, Thomas K: Prediction of individual response to controlled ovarian hyperstimulation by means of a clomiphene citrate challenge test. Fertil Steril 53:295-301, 1990
22. Tanbo T, Dale PO, Abyhom T, Stokke KT: Follicle-stimulating hormone as a prognostic indicator in clomiphene citrate/ human menopausal gonadotrophin-stimulated cycles for in vitro fertilization. Hum Reprod 6:647-650, 1989
23. Tanbo T, Dale PO, Ludne O, Norman N, Abyholm T: Prediction of response to controlled ovarian hyperstimulation: A comparison of basal and clomiphene citrate-stimulated follicle stimulating hormone levels. Fertil Steril 53:295-301, 1990
24. Scott RT, Leonardi MR, Hofmann GE, Illions EH, Neal GS, Navot D: A prospective evaluation of clomiphene citrate challenge test screening in the general infertility population. Obstet Gynecol 82:539-545, 1993
25. Nader S, Berkowitz AS: Use of the hormonal response to clomiphene citrate as an endocrinological indicator of ovarian aging. Human Reprod 6:931-933, 1991
26. Sharara FI, Beatse SN, Leonardi MR, Navot D, Scott RT: Cigarette smoking accelerates the development of diminished ovarian reserve as evidenced by the clomiphene citrate challenge test (CCCT). Fertil Steril 62:257-262, 1994
27. Scott RT, Leonardi MR, Neal GS, Toner JP, Illions EH, Hofmann GE: Comparison of the relative predictive values of abnormal day 3 and day 10 FSH concentrations in the clomiphene citrate challenge test. in review-Fertil Steril
28. Scott RT, Opsahl MS, Leonardi MR, Neal GS, IIlions EH, Navot D: Life table analysis of cumulative pregnancy rates based on the results of ovarian reserve screening and patient age in a general infertility population. in review-Fertil Steril
29. Scott RT, Dellinger CL, Leonardi MR, Illions EH, Hofmann GE, Navot D. Evaluation of the significance of a poor estradiol response during the clomiphene citrate challenge test. Fertil Steril 60:242-246, 1993
30. Hershlag A, Lesser M, Montefusco D, Lavy G, Kaplan P, Liu HC, Rosenfeld D: Interinstitutional variability of follicle-stimulating hormone and estradiol levels. Fertil Steril 58:1123-1126, 1992
31. Muasher SJ: Treatment of low responders. J Assist Reprod Genetics 10:112-114, 1993
32. Olivennes F, Fanchin R, De Ziegler D, Frydman R: "Poor responders": Screening and treatment possibilities. J Assist Reprod Genetics 10:115-117, 1993
33. Ben Rafael Z, Feldberg R: The poor-responder patient in an in vitro fertilization-embryo transfer program. J Assist Reprod Genetics 10:118-120, 1993
34. Ben Rafael Z, Strauss JF, Mastroianni L, Flickinger GL: Differences in ovarian stimulation in human menopausal gonado- tropin treated women may be related to FSH accumulation. Fertil Steril 46:586-589, 1986
35. Ben Rafael Z, Benadiva CA, Ausmanas M, Barber B, Blasco L, Flickinger GL, Mastroianni L: Dose of human menopausal gonadotropin influences the outcome of an in vitro fertilization program. Fertil Steril 48:964-968, 1987
36. Hofmann GE, Toner JP, Muasher SJ, Jones GS: High-dose follicle stimulating hormone (FSH) ovarian stimulation in low responder patients for in vitro fertilization. J In Vitro Pert Embryo Trans 6:285-289, 1993
37. Karande VC, Jones GS, Veeck L, Muasher SJ: High-dose FSH stimulation at the onset of the stimulation at the onset of the menstrual cycle does not suppress the IVF outcome of lowresponder patients. Fertil Steril 53:486-490, 1990
38. Land JA, Yarmolinskaya MI, Dumoulin JCM, Evers JLH: High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome. Fertil Steril 65:961-965, 1996
39. Ben Rafael Z, Menashe Y, Mimon R, Lipitz S, Bider D, Zolti Z, Dan U, Pariente C, Shalev J, Dor J, Lev-Ran D, Mashiach S: Limitations in the use of combined gonadotropin releasing hormone analog and human menopausal gonadotropin for in vitro fertilization. Mashiach S, Ben Rafael Z, Laufer N, Schenker JA (eds): In Advances in Assisted Reproductive Technologies. New York/London, Plenum Press, 1990, pp 17-29
40. Droesch K, Muasher ST, Brzyski R, Jones SG, Simonetti S, Liu HCH, Rosenwaks Z: Value of suppression with a GnRHa prior to gonadotropin stimulation for in vitro fertilization. Fertil Steril 51:292-295, 1989
41. Serafini P, Stone B, Kerin J, Banrofin J, Quinn P, Marrs R: An alternate approach to controlled ovarian hyperstimulation in "poor responders": Pretreatment with a gonadotropin-releasing hormone analog. Fertil Steril 49:90-94, 1988
42. Feldberg D, Farhi J, Ashkenazi J, Dicker D, Shalev J, Ben Rafael Z: Minidose gonadotropin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulation hormone levels. Fertil Steril
43. Padilla SL, Bayati J, Garcia JE: Prognostic value of the early serum estradiol response to leuprolide acetate in in vitro fertilization. Fertil Steril 53:288-294, 1990
44. Garcia JE, Padilla SL, Bayati J, Baramki TA: Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: A better alternative for ovulation induction in in vitro fertilization. Fertil Steril 53:302-305, 1990
45. Diedrich K, Schmutzler R, Diedrich C, van der Ven H, AlHasani S, Krebs D: Experience with GnRH-agonists in ovarian stimulation. In Mashiach S, Ben Rafael Z, Laufer N, Schenker JA (eds): Advances in Assisted Reproductive Technologies. New York/London, Plenum Press, 1990, pp 65-76
46. Padilla SL, Dugan K, Maruschak V, Shalika S, Smith RD: Use of the flare-up protocol with high dose human follicle stimulating hormone and human menopausal gonadotropins for in vitro fertilization in poor responders. Fertil Steril 65:796-799, 1996
47. Bider D, Ben-Rafael Z, Shalev J, Goldenberg M, Mashiach S, Blankstein J: Pituitary and ovarian suppression rate after high dosage of gonadotropin-releasing hormone agonist. Fertil Steril 51:578-581, 1989
48. Brzyski RG, Muasher SJ, Droesch K, Simonetti S, Jones GS, Rosenwaks Z: Follicular atresia associates with concurrent initiation of gonadotropin-releasing hormone agonist and follicle-stimulating hormone for oocyte recruitment. Fertil Steril 50:917-921, 1988
49. Navot D, Rosenwaks Z, Anderson F, Hodgen GD: Gonadotropin releasing hormone agonist-induced ovarian hyperstimulation: Low dose side effects in women and monkeys. Fertil Steril 55:1069-1075, 1991
50. Scott RT, Navot D: Enhancement of ovarian responsiveness with micro-doses of GnRH-agonist during ovulation induction for in vitro fertilization. Fertil Steril 61:880-885, 1994
51. Adashi EY, Resnick CE, Hernandez ER, Hurwitz A, Roberts CT, LeRioth D, Rosenfeld R: Insulin like growth factor I as an intra-ovarian regulator: Basic and clinical implications. Ann NY Acad Sci 626:161-167, 1991
52. Homburg R, Eshel A, Abdulla HI, Jacobs HS: Growth hormone facilitates ovulation induction by gonadotropins. Clin Endocrinol 29:113-115, 1988
53. Menashe Y, Lunenfeld B, Pariente C, Frenkel Y, Mashiach S: Can GH increase after clonidine administration predict the dose of human menopausal hormone needed for induction of ovulation? Fertil Steril 53:432-435, 1990
54. Coukos G, Artini PG, Volpe A, Silferi M, Barreca A, Minuto F, Genazzani GR: Improvement of ovarian response to induction of superovulation with combined growth hormone-gonadotropin treatment. In Mashiach S, Ben Rafael Z, Laufer N, Schenker JA (eds): Advances in Assisted Reproductive Technologies. New York/London, Plenum Press, 1990, pp 389-395
55. Ibrahim ZHZ, Lieberman BA, Matson PL, Buck P: The use of biosynthetic growth hormone to augment ovulation induction with buserelin acetate/human menopausal gonadotropin during controlled ovarian hyperstimulation for in vitro fertilization in women with a poor ovarian response. Fertil Steril 55:202-205, 1991
56. Owen EJ, West C, Mason BA, Jacobs HS: Co-treatment with growth hormone of suboptimal responders in IVF-ET. Hum Reprod 6:529-533, 1991
57. Younis JS, Simon A, Koren R, Dorembus D, Shenker JG, Laufer N: The effect of growth hormone supplementation on in vitro fertilization outcome: A prospective randomized, placebo controlled double blind study. Fertil Steril 58:575-580, 1992
58. Bergh C, Hillensjo T, Wikland M, Nilsson L, Borg G, Hamberger L: Adjuvant growth hormone treatment during in vitro fertilization: A randomized, placebo-controlled study. Fertil Steril 62:113-120, 1994
59. Suikkara AM, MacLachlan V, Koistinen R, Seppala M, Healy DL: Double-blind placebo controlled study: Human biosynthetic growth hormone for assisted reproductive technology. Fertil Steril 65:800-805, 1996
60. Cohen J, Alikani M, Trowbridge J, Rosenwaks Z: Implantation enhancement by selective assisted hatching using zona drilling of embryos with poor prognosis. Hum Reprod 7:685-691, 1992
61. Schoolcraft WB, Schlenker T, Gee M, Jones GS, Jones HW: Efficacy of assisted hatching in poor prognosis IVF candidates. Fertil Steril 62:551-554, 1994
62. Flood JT, Chillik CF, van Uem JFHM, Iritani A, Hodgen GD: Ooplasmic transfusion: Prophase germinal vesicle oocytes made developmentally competent by microinjection of metaphase II egg cytoplasm. Fertil Steril 53:1049-1054, 1990
63. Keefe DL, Niven-Fairchild T, Powell S, Buradagunta S: Mitochondrial deoxyribonucleic acid deletion in oocytes and reproductive aging in women. Fertil Steril 64:577-583, 1995